BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7122105)

  • 1. Indomethacin therapy in premature infants with patent ductus arteriosus.
    Rasidi C; Madiyono B; Usman IN
    Paediatr Indones; 1982; 22(3-4):70-6. PubMed ID: 7122105
    [No Abstract]   [Full Text] [Related]  

  • 2. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 3. [Indomethacin treatment of persistent ductus arteriosus in premature infants].
    Petersen S; Christensen NC; Lauridsen P; Pedersen SA; Ryssing E
    Ugeskr Laeger; 1983 Nov; 145(46):3564-7. PubMed ID: 6649140
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonsurgical closure of patent ductus arteriosus in preterm infants.
    Smith ME
    Heart Lung; 1979; 8(2):308-10. PubMed ID: 253708
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of patent ductus arteriosus in premature and newborn infants].
    Bartel J
    Kinderarztl Prax; 1978 Dec; 46(12):644-8. PubMed ID: 366238
    [No Abstract]   [Full Text] [Related]  

  • 6. [Closure of persistent ductus arteriosus in premature infants by drug therapy].
    Hencz P; Kertész E; Beviz J; Szeleczki T; Szekeres Z
    Orv Hetil; 1981 Oct; 122(41):2535-40. PubMed ID: 7033879
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
    Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
    Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indomethacin for closure of persisting ductus arteriosus in the premature infant].
    Linderkamp O; Versmold HT
    Monatsschr Kinderheilkd; 1981 Feb; 129(2):118-20. PubMed ID: 6112670
    [No Abstract]   [Full Text] [Related]  

  • 9. Indomethacin for closure of patent ductus arteriosus in preterm neonates.
    Nair PA; Karan S
    Indian J Pediatr; 1986; 53(4):499-503. PubMed ID: 3804391
    [No Abstract]   [Full Text] [Related]  

  • 10. In partial defense of prolonged indomethacin therapy for patent ductus arteriosus.
    Hammerman C
    J Pediatr; 2000 May; 136(5):707-8. PubMed ID: 10802512
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
    Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibuprofen and patent ductus arteriosus.
    Clyman RI
    N Engl J Med; 2000 Sep; 343(10):728-30. PubMed ID: 10974138
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of symptomatic patient ductus arteriosus in premature infants.
    Ho LY
    J Singapore Paediatr Soc; 1986; 28(1-2):153-62. PubMed ID: 3762074
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacologic treatment of patent ductus arteriosus in premature infants].
    Vázquez C; Cabrera A; Pastor E; Valls y Soler A
    An Esp Pediatr; 1983 Jun; 18(6):482-8. PubMed ID: 6625369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of indomethacin in the closure of patent ductus arteriosus in premature newborn infants with cardiac insufficiency. Analysis of 14 cases].
    Atik E; Moromizato JH; Zan R; Ajzenberg M; Esher R; Diniz EM; Souza AT; Martins CO; Bastos JC
    Arq Bras Cardiol; 1984 Sep; 43(3):185-9. PubMed ID: 6535546
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Criteria for use of indomethacin injection in neonates.
    Renfro WH; Burr JM; Rawlings J
    Clin Pharm; 1993 Mar; 12(3):232-4. PubMed ID: 8491081
    [No Abstract]   [Full Text] [Related]  

  • 20. [Closure of the ductus arteriosus by medication in low birth weight infants].
    Polgár M; Kemény J; Szirmai Z
    Orv Hetil; 1979 Oct; 120(43):2613-4. PubMed ID: 545236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.